ACELYRIN Inc SLRN.OQ SLRN.O is expected to show no change in quarterly revenue when it reports results on May 12 (estimated) for the period ending March 31 2025
LSEG's mean analyst estimate for ACELYRIN Inc is for a loss of 50 cents per share.
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts had fallen by about 5.3% in the last three months.
Wall Street's median 12-month price target for ACELYRIN Inc is $8.00, above its last closing price of $2.46.
This summary was machine generated May 9 at 20:50 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments